Drug · DIN 02483505
BELSOMRA
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 11, 2019.
- Drug Identification Number (DIN)
- 02483505
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Suvorexant N05CJ01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUVOREXANT | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 29, 2018: NOC 21585New Drug Submission (NDS)
Other DINs named BELSOMRA
- DIN 02483513 · Cancelled Post Market
- DIN 02483521 · Cancelled Post Market
- DIN 02483548 · Cancelled Post Market